BMT-话题@MedSci - 梅斯（MedSci）

#BMT#

14篇内容 | 1028人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1984935, encodeId=50ce198493548, content=<a href='/topic/show?id=a00b35938b' target=_blank style='color:#2F92EE;'>#BMT#</a>, objectTitle= ACAS应该选择BMT还是CEA/CAS？, objectType=article, longId=215512, objectId=cc3e2155120c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc3e2155120c, replyNumber=0, likeNumber=77, createdTime=2021-12-22, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc3e2155120c, moduleTitle= ACAS应该选择BMT还是CEA/CAS？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cc3e2155120c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984936, encodeId=3b6819849363c, content=<a href='/topic/show?id=a00b35938b' target=_blank style='color:#2F92EE;'>#BMT#</a>, objectTitle=无症状患者，首选BMT患者，期间多长时间复查，查哪些？, objectType=article, longId=215559, objectId=1db5215559bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1db5215559bd, replyNumber=0, likeNumber=63, createdTime=2022-07-17, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1db5215559bd, moduleTitle=无症状患者，首选BMT患者，期间多长时间复查，查哪些？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1db5215559bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984934, encodeId=348b1984934e9, content=<a href='/topic/show?id=a00b35938b' target=_blank style='color:#2F92EE;'>#BMT#</a>, objectTitle=EBMT 2020：LNP023治疗阵发性夜间血红蛋白尿（PNH）取得积极结果, objectType=article, longId=200081, objectId=a896200081fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a896200081fc, replyNumber=0, likeNumber=72, createdTime=2021-05-06, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a896200081fc, moduleTitle=EBMT 2020：LNP023治疗阵发性夜间血红蛋白尿（PNH）取得积极结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a896200081fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984933, encodeId=4f05198493367, content=<a href='/topic/show?id=a00b35938b' target=_blank style='color:#2F92EE;'>#BMT#</a>, objectTitle=2020 EBMT共识建议：血液恶性肿瘤干细胞移植治疗后移植物抗宿主病的预防和管理, objectType=article, longId=187751, objectId=c0cd18e75173, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0cd18e75173, replyNumber=0, likeNumber=60, createdTime=2020-11-09, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0cd18e75173, moduleTitle=2020 EBMT共识建议：血液恶性肿瘤干细胞移植治疗后移植物抗宿主病的预防和管理, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c0cd18e75173)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984932, encodeId=c8e11984932a4, content=<a href='/topic/show?id=a00b35938b' target=_blank style='color:#2F92EE;'>#BMT#</a>, objectTitle=2019 EBMT共识建议：HLA半相合供体淋巴细胞输注的临床应用, objectType=article, longId=180526, objectId=ca0118052645, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca0118052645, replyNumber=0, likeNumber=60, createdTime=2020-02-03, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca0118052645, moduleTitle=2019 EBMT共识建议：HLA半相合供体淋巴细胞输注的临床应用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ca0118052645)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984931, encodeId=cddb198493145, content=<a href='/topic/show?id=a00b35938b' target=_blank style='color:#2F92EE;'>#BMT#</a>, objectTitle=强大阵容！高博医疗集团北京博仁医院8项研究成果亮相APBMT 2019, objectType=article, longId=178621, objectId=a0b21e8621f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0b21e8621f8, replyNumber=0, likeNumber=81, createdTime=2020-08-10, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0b21e8621f8, moduleTitle=强大阵容！高博医疗集团北京博仁医院8项研究成果亮相APBMT 2019, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a0b21e8621f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984929, encodeId=67a019849298a, content=<a href='/topic/show?id=a00b35938b' target=_blank style='color:#2F92EE;'>#BMT#</a>, objectTitle=2018 ASBMT共识：免疫效应细胞相关的细胞因子释放综合征和神经毒性的分级, objectType=article, longId=157863, objectId=126e15e86314, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=126e15e86314, replyNumber=0, likeNumber=56, createdTime=2019-09-15, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=126e15e86314, moduleTitle=2018 ASBMT共识：免疫效应细胞相关的细胞因子释放综合征和神经毒性的分级, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=126e15e86314)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984928, encodeId=dde41984928aa, content=<a href='/topic/show?id=a00b35938b' target=_blank style='color:#2F92EE;'>#BMT#</a>, objectTitle=2018 EWALL/EBMT立场声明：造血干细胞移植治疗成人费城染色体阴性急性淋巴细胞白血病首次缓解, objectType=article, longId=153017, objectId=649b15301eb0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=649b15301eb0, replyNumber=0, likeNumber=53, createdTime=2019-02-15, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=649b15301eb0, moduleTitle=2018 EWALL/EBMT立场声明：造血干细胞移植治疗成人费城染色体阴性急性淋巴细胞白血病首次缓解, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=649b15301eb0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984930, encodeId=e85a198493057, content=<a href='/topic/show?id=a00b35938b' target=_blank style='color:#2F92EE;'>#BMT#</a>, objectTitle=2019 EBMT共识建议：单倍体造血干细胞移植供者的选择, objectType=article, longId=162846, objectId=a92e16284603, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a92e16284603, replyNumber=0, likeNumber=64, createdTime=2019-12-31, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a92e16284603, moduleTitle=2019 EBMT共识建议：单倍体造血干细胞移植供者的选择, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a92e16284603)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984926, encodeId=87091984926e3, content=<a href='/topic/show?id=a00b35938b' target=_blank style='color:#2F92EE;'>#BMT#</a>, objectTitle=2018 EBMT立场声明：造血干细胞移植后患者腺病毒感染的管理, objectType=article, longId=136184, objectId=f16213618431, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f16213618431, replyNumber=0, likeNumber=73, createdTime=2019-01-01, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f16213618431, moduleTitle=2018 EBMT立场声明：造血干细胞移植后患者腺病毒感染的管理, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f16213618431)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984925, encodeId=86a8198492507, content=<a href='/topic/show?id=a00b35938b' target=_blank style='color:#2F92EE;'>#BMT#</a>, objectTitle=Blood：进行自体血液/骨髓移植（BMT）儿童的后期死亡风险评估, objectType=article, longId=135585, objectId=b3db135585ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3db135585ae, replyNumber=0, likeNumber=96, createdTime=2018-04-30, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3db135585ae, moduleTitle=Blood：进行自体血液/骨髓移植（BMT）儿童的后期死亡风险评估, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b3db135585ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984927, encodeId=ffef198492e3a, content=<a href='/topic/show?id=a00b35938b' target=_blank style='color:#2F92EE;'>#BMT#</a>, objectTitle=2018 ASBMT立场声明：多发性硬化作为自体造血干细胞移植的适应证, objectType=article, longId=142310, objectId=66f314231017, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66f314231017, replyNumber=0, likeNumber=65, createdTime=2018-11-23, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66f314231017, moduleTitle=2018 ASBMT立场声明：多发性硬化作为自体造血干细胞移植的适应证, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=66f314231017)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984924, encodeId=3de1198492454, content=<a href='/topic/show?id=a00b35938b' target=_blank style='color:#2F92EE;'>#BMT#</a>, objectTitle=2017 EBMT：如何选择异基因造血干细胞移植的更佳供者----半相合移植的供者选择, objectType=article, longId=95306, objectId=6a35953065a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a35953065a, replyNumber=0, likeNumber=88, createdTime=2018-02-15, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a35953065a, moduleTitle=2017 EBMT：如何选择异基因造血干细胞移植的更佳供者----半相合移植的供者选择, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6a35953065a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1984923, encodeId=ef9c1984923f3, content=<a href='/topic/show?id=a00b35938b' target=_blank style='color:#2F92EE;'>#BMT#</a>, objectTitle=陆道培院士获CIBMTR杰出服务贡献奖, objectType=article, longId=64927, objectId=093f6492e84, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=093f6492e84, replyNumber=0, likeNumber=76, createdTime=2016-04-16, rootId=0, userName=108807375_62823127, userId=18b32500069, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=093f6492e84, moduleTitle=陆道培院士获CIBMTR杰出服务贡献奖, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=093f6492e84)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

BMT

2020-05-29

108807375_62823127 (审核中...)

前往app查看评论内容

#BMT#

ACAS应该选择BMT还是CEA/CAS？

2021-12-22

108807375_62823127 (审核中...)

前往app查看评论内容

#BMT#

无症状患者，首选BMT患者，期间多长时间复查，查哪些？

2022-07-17

108807375_62823127 (审核中...)

前往app查看评论内容

#BMT#

EBMT 2020：LNP023治疗阵发性夜间血红蛋白尿（PNH）取得积极结果

2021-05-06

108807375_62823127 (审核中...)

前往app查看评论内容

#BMT#

2020 EBMT共识建议：血液恶性肿瘤干细胞移植治疗后移植物抗宿主病的预防和管理

2020-11-09

108807375_62823127 (审核中...)

前往app查看评论内容

#BMT#

2019 EBMT共识建议：HLA半相合供体淋巴细胞输注的临床应用

2020-02-03

108807375_62823127 (审核中...)

前往app查看评论内容

#BMT#

强大阵容！高博医疗集团北京博仁医院8项研究成果亮相APBMT 2019

2020-08-10

108807375_62823127 (审核中...)

前往app查看评论内容

#BMT#

2018 ASBMT共识：免疫效应细胞相关的细胞因子释放综合征和神经毒性的分级

2019-09-15

108807375_62823127 (审核中...)

前往app查看评论内容

#BMT#

2018 EWALL/EBMT立场声明：造血干细胞移植治疗成人费城染色体阴性急性淋巴细胞白血病首次缓解

2019-02-15

108807375_62823127 (审核中...)

前往app查看评论内容

#BMT#

2019 EBMT共识建议：单倍体造血干细胞移植供者的选择

2019-12-31

108807375_62823127 (审核中...)

前往app查看评论内容

#BMT#

2018 EBMT立场声明：造血干细胞移植后患者腺病毒感染的管理

2019-01-01

108807375_62823127 (审核中...)

前往app查看评论内容

#BMT#

Blood：进行自体血液/骨髓移植（BMT）儿童的后期死亡风险评估

2018-04-30

108807375_62823127 (审核中...)

前往app查看评论内容

#BMT#

2018 ASBMT立场声明：多发性硬化作为自体造血干细胞移植的适应证

2018-11-23

108807375_62823127 (审核中...)

前往app查看评论内容

#BMT#

2017 EBMT：如何选择异基因造血干细胞移植的更佳供者----半相合移植的供者选择

2018-02-15

108807375_62823127 (审核中...)

前往app查看评论内容

#BMT#

陆道培院士获CIBMTR杰出服务贡献奖

2016-04-16

科室
- - 订阅+
  - 更多科室
工具
服务